All News

CHPA says over $146 billion and countless productivity hours are saved by the availability and accessibility of OTC medications and products. 

The free course will cover a myraid of drug policy issues. 

"Our jobs change, our families change, our kids change, and whether we realize it or not, we change."

Ensure quality by achieving and maintaining competence to administer immunizations. 

Survey shows pharmacists are eager to provide care for the whole patient continuum. 

Aggregated data highlights manufacturers responsible for price increases. 

Study finds different anticoagulation treatment levels for patients with cognitive problems.

A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.

Beginning January 2020, all new employer clients must incorporate Point-of-Sale discounts.

National Gold Status Practice created by a pharmacist looks to expand nationwide. 

It's a seller's market for those looking to transition or divest; buyers must consider profit and continuity in addition to price. 

400 positions consolidated, saving a predicted annual $55 million.

Ongoing valsartan shortages due to recalls prompt FDA prioritization.

Some patients view supplements as more convienent and affordable than medical treatment. 

Although requests for measles vaccinations are increasing, pharmacists may be limited by state laws.

Indicated for breast cancer, and gastric or gastroesophageal junction adenocarcinoma. 

ADA violations net pharmacist over $1 million. 

Recent survey denotes high levels of burnout syndrome.

Relationships and planning will help bring balance to life. 

Schools increase focus on patients, outcomes, economics, and leadership.

 Identify and overcome burnout before it impacts you. 

How do full-time pharmacists stay motivated at work and achieve a perfect work-life balance? Here are four pharmacists who are doing just that.

Only new biosimilars and interchangeables will recieve four-letter suffixes.

Safety monitoring findings for Shingrix are consistent with clinical trial data.

Pregnancy and menopause are contributing factors.

Scott Gottlieb’s tenure at the FDA was marked by hundreds of generic approvals and aggressive moves against the tobacco industry and vaping.

More than 40 companies have been recorded distributing nicotine-containing products to minors.